Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,500.00
-150.00 (-1.73%)
Last updated: Apr 29, 2026, 9:25 AM KST
54.26%
Market Cap 317.11B
Revenue (ttm) 1.66T
Net Income (ttm) 20.97B
Shares Out 36.66M
EPS (ttm) 521.00
PE Ratio 16.60
Forward PE n/a
Dividend 100.00 (1.18%)
Ex-Dividend Date Mar 31, 2026
Volume 43,787
Average Volume 244,833
Open 8,630.00
Previous Close 8,650.00
Day's Range 8,490.00 - 8,650.00
52-Week Range 5,350.00 - 12,800.00
Beta 0.52
RSI 55.06
Earnings Date May 15, 2026

About Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vi... [Read more]

Industry Packaged Foods
Founded 1963
Employees 1,021
Stock Exchange Korea Stock Exchange
Ticker Symbol 009290
Full Company Profile

Financial Performance

In 2025, Kwang Dong Pharmaceutical's revenue was 1.66 trillion, an increase of 1.15% compared to the previous year's 1.64 trillion. Earnings were 20.97 billion, a decrease of -48.20%.

Financial Statements

News

There is no news available yet.